ISHARES TR - U.S. PHARMA ETF (IHE)

CUSIP: 464288836

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / U.S. PHARMA ETF
Total 13F shares
945,004
Share change
-907,209
Total reported value
$139,386,111
Put/Call ratio
58%
Price per share
$147.54
Number of holders
101
Value change
-$139,511,090
Number of buys
25
Number of sells
56

Quarterly Holders Quick Answers

What is CUSIP 464288836?
CUSIP 464288836 identifies IHE - ISHARES TR - U.S. PHARMA ETF in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IHE - ISHARES TR - U.S. PHARMA ETF (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of ISHARES TR - U.S. PHARMA ETF (IHE) as of Q1 2018

As of 31 Mar 2018, ISHARES TR - U.S. PHARMA ETF (IHE) was held by 101 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 945,004 shares. The largest 10 holders included MORGAN STANLEY, BANK OF AMERICA CORP /DE/, BROWN ADVISORY INC, ROYAL BANK OF CANADA, ARS Wealth Advisors, LLC, AMERIPRISE FINANCIAL INC, UBS Group AG, MURPHY CAPITAL MANAGEMENT INC, WELLS FARGO & COMPANY/MN, and RAYMOND JAMES & ASSOCIATES. This page lists 101 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2018 vs Q4 2017 Across Filers

Q4 2017 holders
107
Q1 2018 holders
101
Holder diff
-6
Investor Q4 2017 Shares Q1 2018 Shares Share Diff Share Chg % Q4 2017 Value $ Q1 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .